Effects of KLF9 on liver cancer metastasis and EMT are still elusive, and we originally uncovered that KLF9 functionally suppresses HCC metastasis and EMT in this study, which will be a novel therapeutic target for drug development. The gene discussed is KLF9; the disease is liver cancer.